研究者
J-GLOBAL ID：200901009990380428
更新日: 2024年11月17日
熱田 由子
アツタ ヨシコ | Atsuta Yoshiko
所属機関・部署：
職名：
センター長
競争的資金等の研究課題 (3件)：
- 2011 - 2012 造血幹細胞移植後晩期障害と患者QOLに関する研究
- 2009 - 2011 アジアにおける造血細胞移植登録システムの構築
- 2007 - 2008 本邦における造血幹細胞移植後二次癌の頻度・リスクに関する研究
論文 (426件)：
-
Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, et al. Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy. Hematological oncology. 2024. 42. 6. e3315
-
Makoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, Koji Kato, Hiroyuki Muranushi, Masahito Tokunaga, Ayumu Ito, Jun Ishikawa, Tetsuya Eto, Satoko Morishima, et al. Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma. British journal of haematology. 2024
-
Atsushi Marumo, Yasunobu Nagata, Machiko Fujioka, Shuhei Kurosawa, Yuho Najima, Emiko Sakaida, Noriko Doki, Kentaro Fukushima, Shuichi Ota, Katsuhiro Shono, et al. Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome. Cytotherapy. 2024
-
Masaharu Tamaki, Shunto Kawamura, Kosuke Takano, Hirohisa Nakamae, Noriko Doki, Hiroyuki Ohigashi, Yumiko Maruyama, Shuichi Ota, Nobuhiro Hiramoto, Tetsuya Eto, et al. Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation. Cytotherapy. 2024
-
Machiko Fujioka, Hidehiro Itonaga, Hideyuki Nakazawa, Tetsuya Nishida, Keisuke Kataoka, Takashi Ikeda, Shinichi Kako, Ken-Ichi Matsuoka, Koji Adachi, Shini-Chiro Fujiwara, et al. Superior survival after unrelated allogeneic stem cell transplantation with low-dose ATG compared to low-dose TBI in myeloablative fludarabine/busulfan-based regimen for MDS on behalf of the adult MDS Working Group of the JSTCT. Transplantation and cellular therapy. 2024
もっと見る
MISC (103件)：
-
岡田 陽介, 木村 文彦, 栗田 尚樹, 高橋 寛行, 島津 裕, 水野 昌平, 内田 直之, 片岡 圭亮, 平本 展大, 太田 秀一, et al. アグレッシブ非ホジキンリンパ腫および多発性骨髄腫に対する自家移植後に起こる血小板生着遅延の影響. 日本血液学会学術集会. 2023. 85回. 73-73
-
森 拓人, 越智 陽太郎, 昆 彩奈, 吉里 哲一, 古関 明彦, 依田 成玄, 中川 正宏, 竹田 淳恵, 永田 安伸, 吉田 健一, et al. 骨髄異形成症候群におけるSRSF2変異とSTAG2変異と協調的関係(Cooperative effects of SRSF2 and STAG2 mutations on development of myelodysplastic syndrome and its related disorders). 日本癌学会総会記事. 2022. 81回. IS11-6
-
Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, et al. Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD. 2021. 138. 3692-+
-
Yoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, Tadakazu Kondo, Shohei Mizuno, Junya Kanda, Takahiro Fujino, Keisuke Kataoka, Naoyuki Uchida, Tetsuya Eto, et al. Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia. BLOOD. 2021. 138. 1790-+
-
Kyoko Fuse, Masayoshi Masuko, Shohei Mizuno, Kaito Harada, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Kazuhiro Ikegame, et al. Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML. BLOOD. 2020. 136
もっと見る
経歴 (1件)：
- 名古屋大学 医学部 寄附講座 名古屋大学医学部寄附講座(医学部) 寄附講座講師
前のページに戻る
